Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

61.37USD
23 Feb 2018
Change (% chg)

$1.94 (+3.26%)
Prev Close
$59.43
Open
$59.55
Day's High
$61.44
Day's Low
$59.31
Volume
58,256
Avg. Vol
44,014
52-wk High
$62.99
52-wk Low
$21.95

Latest Key Developments (Source: Significant Developments)

Ascendis Pharma Initiates Submissions In Australia To Enter Study With Transcon CNP
Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Ascendis Pharma A/S ::ASCENDIS PHARMA SAYS ON DEC 20, INITIATED REGULATORY SUBMISSIONS IN AUSTRALIA TO ENTER INTO FIRST HUMAN CLINICAL STUDY WITH TRANSCON CNP - SEC FILING.  Full Article

Ascendis Pharma A/S Q3 loss per share EUR 1.04
Thursday, 16 Nov 2017 

Nov 16 (Reuters) - Ascendis Pharma A/S ::Ascendis Pharma A/S reports third quarter 2017 financial results.Q3 loss per share EUR 1.04.Q3 earnings per share view EUR -0.74 -- Thomson Reuters I/B/E/S.  Full Article

Ascendis Pharma reports Q2 loss per share EUR 0.53
Wednesday, 31 Aug 2016 

Ascendis Pharma A/S : Ascendis Pharma A/S reports second quarter 2016 financial results and provides business update . Q2 loss per share eur 0.53 . Qtrly revenue euro 1.1 million versus euro 1.9 million .Q2 earnings per share view $-0.69 -- Thomson Reuters I/B/E/S.  Full Article

Ascendis Pharma A/S files for potential share offering of up to $250 mln
Friday, 20 May 2016 

Ascendis Pharma A/S :Ascendis Pharma A/S files for potential share offering of up to $250 million - SEC filing.  Full Article

Ascendis Pharma A/S reports Q1 loss of 0.82 euros per share
Thursday, 19 May 2016 

Ascendis Pharma A/S : Ascendis Pharma A/S reports first quarter 2016 financial results . Q1 loss per share eur 0.82 .Q1 revenue fell 40 percent to eur 1.3 million.  Full Article